Deployment
Versius at United States
CMR Surgical (founded 2014, Cambridge, UK; private) makes Versius, the genuine challenger among surgical-robot startups and the one that has clearly crossed the regulatory gating event. Versius is a modular multi-arm teleoperated soft-tissue robot that is heavily software-driven, capturing telematic, video, and outcome data. It received US FDA De Novo marketing authorization in October 2024, the first such authorization for a multi-port soft-tissue general-surgery robot, followed by an FDA 510(k) clearance for the next-generation Versius Plus on December 18, 2025 with US commercialization on track for 2026, and a pending gynecology 510(k) submitted on April 29, 2026; it has long been CE-marked and commercial across Europe, Latin America, the Africa-Middle-East region, and Australia, with more than 40,000 procedures completed outside the US by company reporting.
The registry records it at commercial maturity with an active lifecycle. An important current-state correction: the 2021 roughly $3 billion SoftBank-led valuation story is frozen in time, the company went through real restructuring in 2023 with about 350 redundancies, and it was recapitalized with more than $200 million in April 2025, while reported figures of a roughly $3.1 billion 2025 valuation and a potential $4 billion sale are rumor-tier aggregator claims that are not registered.
On AI substance the shipped reality is a data-capture and analytics ecosystem with the surgeon in full control; the physical-AI framing is forward-looking, anchored in a March 2026 NVIDIA IGX Thor partnership to evaluate AI for a future Versius, with no autonomous or AI-assisted intraoperative feature cleared or shipped.
Versius by CMR Surgical · Catalog entry · 1 source · not yet field-verified · Surgical robots
Recent coverage
- Stryker invests $400M into CMR SurgicalThe Robot Report · 2026-10-15
- Stryker to Invest $400M in CMR Surgical, Gains U.S. Sales Rights and Acquisition OptionThe AI Insider · 2026-10-12
- CMR Surgical secures 510k clearance of Versius Plus robotic surgical systemBen Smith, Deploy Editor · 2026-06-09
CMR Surgical said in December 2025 that it received FDA 510(k) clearance for Versius Plus for gallbladder removal, and that it was on track to begin launching the system in the U.S. in 2026. The robot is modular, so it can be moved between operating rooms.
Key facts
- FDA clearance
- Dec 2025 (Versius Plus)
- US launch
- Planned for 2026
Safety record
No incidents on record for Versius at United States.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
- Trust tier
- Catalog entry · 1 source · not yet field-verifiedhow tiers work →
- Last updated
- 2026-11-01
- Model
- Versius
- Company
- CMR Surgical
- Location
- United States
- Operator
- CMR Surgical
- Status
- announced
- First seen
- 2025-12-01
- ID
e6d82d75-839b-431e-9edc-649379ddb6e8
Timeline
- Dec 2025First recordedVersius first documented operating at United States.
- Nov 2026Current status: announced, reviewedLatest recorded state. New status transitions append here as the deployment-status recorder produces them.
On the deployment map
Operates worldwide
Versius is deployed globally rather than at a single verified site, so there is no map pin.
Versius operates in United States. Explore the full verified map:
Sources (1)
Methodology: Verified · 1 source (no primary) · last reviewed 2026-11-01
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-11-01
Maturity + lifecycle
Maturity stage: commercial
Lifecycle: active
Architectural position
Cohort: surgical
Sources by quality tier
- 1
- secondary-trade-publication
- Trade publication
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for Versius at United States.Common questions
What is the Versius deployment at United States?
Who operates Versius at United States?
When did the Versius deployment at United States go live?
Is the Versius deployment at United States still active?
Have there been incidents at the Versius deployment at United States?
Deploy Watch
Track this deployment.
We notify you when status changes against primary-source evidence, contract events surface, or a related incident is filed.
Machine-readable surfaces
- Markdown mirror: /deployments/cmr-versius-plus-fda-us-2026.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/robots/e6d82d75-839b-431e-9edc-649379ddb6e8
- Data documentation: /data
- Query this programmatically: Deploy MCP